Cargando…

Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center

The prevalence of chronic kidney disease (CKD) is high in patients with atrial fibrillation (AF). Left atrial appendage closure (LAAC) has been recognized as an efficient alternative to oral anticoagulation for the prevention of thromboembolic events in patients with non-valvular AF (NVAF); however,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Xin, Jiang, Lisheng, Duenninger, Erich, Muenzel, Manuela, Guan, Shaofeng, Fazakas, Adam, Cheng, Fanzhou, Illnitzky, Juergen, Keil, Thorsten, Yu, Jiangtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096728/ https://www.ncbi.nlm.nih.gov/pubmed/29564543 http://dx.doi.org/10.1007/s00380-018-1157-x

Ejemplares similares

Left Atrial Appendage Closure – The WATCHMAN Device
por: Akinapelli, Abhilash, et al.
Publicado: (2015)

Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience
por: Zhao, Mingzhong, et al.
Publicado: (2021)

The Canadian WATCHMAN Registry for Percutaneous Left Atrial Appendage Closure
por: Saw, Jacqueline, et al.
Publicado: (2023)

Watchman Left Atrial Appendage Closure After Incomplete AtriClip Closure
por: Ice, Daniel S., et al.
Publicado: (2022)

Impact of conscious sedation and general anesthesia on periprocedural outcomes in Watchman left atrial appendage closure
por: Kleinecke, Caroline, et al.
Publicado: (2021)

Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings
por: Sakriss, Charlotte, et al.
Publicado: (2023)

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
por: Ke, Jin-Yan, et al.
Publicado: (2022)

Recurrent Left Pleural Effusion Following Left Atrial Appendage Closure With the Watchman Device
por: Halaby, Rim, et al.
Publicado: (2020)

Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure With the WATCHMAN Device
por: Tan, Bryan E-Xin, et al.
Publicado: (2021)

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
por: Reddy, Vivek Y., et al.
Publicado: (2016)

Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry
por: Phillips, Karen P., et al.
Publicado: (2019)

Comparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females
por: Alhuarrat, Majd Al Deen, et al.
Publicado: (2023)

Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure
por: Fukuda, Nobuyuki, et al.
Publicado: (2022)

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
por: Alipour, Arash, et al.
Publicado: (2017)

Device-Associated Thrombus with Watchman FLX Left Atrial Appendage Closure Device: A Report of Two Cases
por: Dhaduk, Nehal, et al.
Publicado: (2023)

The Added Value of Preprocedural Cardiac Computed Tomography in Planning Left Atrial Appendage Closure With the Watchman FLX Device
por: Kassab, Joseph, et al.
Publicado: (2023)

Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage
por: Nandar, Phoo Pwint, et al.
Publicado: (2018)

Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
por: Zhai, Zhengqin, et al.
Publicado: (2019)

WATCHMAN FLX implantation with an extremely small left atrial appendage ostium
por: Yano, Masamichi, et al.
Publicado: (2022)

Impact of Thrombocytopenia in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison of 190 Consecutive Watchman Implantations
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
por: Boersma, Lucas V.A., et al.
Publicado: (2016)

Small thrombi and incomplete endothelialization detected by cardiac endoscopy after left atrial appendage closure using Watchman device
por: Abe, Ryo, et al.
Publicado: (2020)

Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience
por: Saad, Mohammed, et al.
Publicado: (2021)

A Comparative Study of Three Imaging Modalities for Size Selection of a Watchman Left Atrial Appendage Closure Device
por: Ruan, Zhong-bao, et al.
Publicado: (2022)

Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2019)

Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement
por: Ahuja, Tania, et al.
Publicado: (2019)

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Left atrial appendage closure with Watchman device: Insights from the first-ever Tunisian experience and six-year follow-up
por: Chamtouri, Ikram, et al.
Publicado: (2021)

Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device
por: Luani, Blerim, et al.
Publicado: (2017)

Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device
por: Luani, Blerim, et al.
Publicado: (2019)

Personalized Fluoroscopic Angles in Watchman™ Left Atrial Appendage Closure Landing Zone Assessment: A Three-Dimensional Printed Simulation Study
por: Shee, Vikram, et al.
Publicado: (2020)

Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
por: Prabhakar Bhat, Sangeeta, et al.
Publicado: (2021)

Correction to: Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience
por: Phillips, Karen P., et al.
Publicado: (2016)

Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up
por: Phillips, Karen P, et al.
Publicado: (2018)

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Comparison of intracardiac vs. transesophageal echocardiography for “one-stop” procedures of combined radiofrequency catheter ablation and left atrial appendage closure with the Watchman device in the treatment of atrial fibrillation
por: Shang, Xining, et al.
Publicado: (2023)

Safety and efficacy of percutaneous atrial appendage closure followed by antiplatelet therapy in a high-risk population: single-center experience with a WATCHMAN device
por: Maksym, Jakub, et al.
Publicado: (2023)

Utilization of WATCHMAN FLX for surgically incomplete left atrial appendage occlusion: a multicentre case series
por: Golzarian, Hafez, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_256gmtjs1jr6n43u7559mvd4pd